MARKET

AUPH

AUPH

Aurinia Pharmace
NASDAQ
16.08
-0.04
-0.25%
After Hours: 16.08 0 0.00% 19:30 09/04 EDT
OPEN
15.97
PREV CLOSE
16.12
HIGH
16.22
LOW
15.93
VOLUME
526.59K
TURNOVER
--
52 WEEK HIGH
19.25
52 WEEK LOW
10.34
MARKET CAP
2.14B
P/E (TTM)
7.02
1D
5D
1M
3M
1Y
5Y
1D
13D Filings
Barron‘s · 2d ago
Weekly Report: what happened at AUPH last week (0824-0828)?
Weekly Report · 08/31 09:47
Weekly Report: what happened at AUPH last week (0817-0821)?
Weekly Report · 08/24 09:47
KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts
TipRanks · 08/22 09:02
Aurinia Shares Gains After Settling Patent Lawsuit With Teva
Dow Jones · 08/20 15:51
Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug
Benzinga · 08/20 13:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Ascendis Pharma (ASND) and Aurinia Pharmaceuticals (AUPH)
TipRanks · 08/20 12:10
Aurinia Pharmaceuticals (AUPH) Gets a Buy from TD Cowen
TipRanks · 08/20 09:45
More
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.

Webull offers Aurinia Pharmaceuticals Inc stock information, including NASDAQ: AUPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform.